We have a few key things we are waiting on such as financing, sample size assessment and possibly an FA.

I was rambling on Zenith and it lead me back to thinking about the financing at RVX. CD Venture owns 2.3% of RVX or about 4,000,000 shares, slightly less than Don. Christoph Boehringer is a co-owner and managing director of CD Ventures. He is a 4th generation very wealthy member of the Boehringer family of Boehringer Ingelheim Pharma company which is looking for growth and external partners.

Anyway, I found an interesting article at https://www.bloomberg.com/news/articles/2017-07-17/this-secretive-clan-wants-to-beat-the-world-s-biggest-drugmakers

I wonder if he is representing the eyes and ears of Boehringer Ingelheim. That could be a company that could give RVX and apabetalone a base in the EU. Boehringer Ingelheim is privately held and strong in R & D but now they are looking at external R & D as well to help fuel their growth.

Note that CD Venture is completely separate from Boehringer Ingelheim.

FYI

Cheers

Toinv